PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Autor:	Suchankova, E, Doležal, T, Pisarikova, Z, Rychna, K, Bartaskova, D
Zdroj:	In Value in Health 2009 12(7):A405-A406
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect Plný text